Adolescent and young adult (AYA) cancer patients suffer from delay in diagnosis, and lack of centralized cancer care, age-adjusted expertise, and follow-up care. This group presents with a unique spectrum of cancers, distinct tumor biology, cancer risk factors, developmental challenges, and treatment regimens that differ from children and older adults. It is imperative for advances in the field of AYA oncology to pool data sources across institutions and create large cohorts to address the many pressing questions that remain unanswered in this vulnerable population. We will create a nationwide infrastructure (COMPRAYA) for research into the incidence, predictive/prognostic markers, and underlying mechanisms of medical and psychosocial outcomes for AYA between 18–39 years diagnosed with cancer. A prospective, observational cohort of (n = 4000), will be es-tablished. Patients will be asked to (1) complete patient-reported outcome measures; (2) donate a blood, hair, and stool samples (to obtain biochemical, hormonal, and inflammation parameters, and germline DNA); (3) give consent for use of routinely archived tumor tissue and clinical data extraction from medical records and registries; (4) have a clinic visit to assess vital parameters. Systematic and comprehensive collection of patient and tumor characteristics of AYA will support the development of evidence-based AYA care programs and guidelines.
Bibliographical noteFunding Information:
Funding: The COMPRAYA study was funded by an infrastructural grant (#11788) of the Dutch Cancer Society (Amsterdam, The Netherlands). Olga Husson is supported by a personal research grant (VIDI; #198.007—Facing the unthinkable in the prime of life: Prevalence, risk factors, and mechanisms of impaired medical and psychosocial health outcomes among adolescents and young adults with cancer) of The Netherlands Organization for Scientific Research.
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.